JPS56131523A - Vaccine composite containing idiosyncratic antigen and vaccine containing idiosyncratic antigen - Google Patents
Vaccine composite containing idiosyncratic antigen and vaccine containing idiosyncratic antigenInfo
- Publication number
- JPS56131523A JPS56131523A JP2418381A JP2418381A JPS56131523A JP S56131523 A JPS56131523 A JP S56131523A JP 2418381 A JP2418381 A JP 2418381A JP 2418381 A JP2418381 A JP 2418381A JP S56131523 A JPS56131523 A JP S56131523A
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- idiosyncratic
- vaccine
- composite
- composite containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8003707A FR2475900A1 (fr) | 1980-02-20 | 1980-02-20 | Complexe vaccinal contenant un antigene specifique et vaccin le contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS56131523A true JPS56131523A (en) | 1981-10-15 |
Family
ID=9238765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2418381A Pending JPS56131523A (en) | 1980-02-20 | 1981-02-20 | Vaccine composite containing idiosyncratic antigen and vaccine containing idiosyncratic antigen |
Country Status (10)
Country | Link |
---|---|
US (1) | US4460575A (ja) |
EP (1) | EP0035429B1 (ja) |
JP (1) | JPS56131523A (ja) |
AT (1) | ATE13741T1 (ja) |
AU (1) | AU543201B2 (ja) |
CA (1) | CA1181691A (ja) |
DE (1) | DE3170913D1 (ja) |
ES (1) | ES500567A0 (ja) |
FR (1) | FR2475900A1 (ja) |
ZA (1) | ZA811125B (ja) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4870053A (en) * | 1980-09-19 | 1989-09-26 | Roussel Uclaf | Novel compositions and processes |
US5567587A (en) * | 1983-01-10 | 1996-10-22 | Gen-Probe Incorporated | Method for detecting, the presence and amount of prokaryotic organisms using specific rRNA subsequences as probes |
US4650675A (en) * | 1983-08-18 | 1987-03-17 | The Children's Medical Center Corporation | Oligonucleotide conjugates |
GB8404280D0 (en) * | 1984-02-17 | 1984-03-21 | Stanford J L | Biological preparations |
US5346999A (en) * | 1985-01-18 | 1994-09-13 | Applied Biosystems, Inc. | Method of nucleic acid extraction |
US4692332A (en) * | 1985-01-18 | 1987-09-08 | Mcmichael John | Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms |
US4689222A (en) * | 1985-01-18 | 1987-08-25 | Mcmichael John | Methods and materials for alleviation of pain symptoms of malignant neoplasia |
JPS62502262A (ja) * | 1985-03-27 | 1987-09-03 | ブロンコスタット・プロプライアタリー・リミテツド | アジユバントを含有しないワクチン |
EP0220308A1 (en) * | 1985-04-30 | 1987-05-06 | Scripps Clinic And Research Foundation | Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods |
US4701323A (en) * | 1985-10-23 | 1987-10-20 | Iowa State University Research Foundation, Inc. | Vaccines for counteracting inhibition of neutrophil degranulation |
US4681761A (en) * | 1985-10-24 | 1987-07-21 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine |
FR2619122B1 (fr) * | 1987-08-03 | 1990-03-09 | Pasteur Institut | Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede |
US5346891A (en) * | 1990-08-20 | 1994-09-13 | Gen-Ichiro Soma | Lipopolysaccharide-producing bacteria, lipopolysaccharides, and lipopolysaccharide-containing, medicines and veterinary medicines |
US7279162B1 (en) * | 1990-10-22 | 2007-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection |
US5506129A (en) * | 1991-05-24 | 1996-04-09 | Evans Medical Limited | Virus production |
JPH09163896A (ja) * | 1995-12-13 | 1997-06-24 | Sumitomo Pharmaceut Co Ltd | 胸膜炎病態モデル動物 |
FR2745186B1 (fr) * | 1996-02-26 | 1998-12-31 | Torossian Fernand Narbey | Complexe immunomodulateur et ses utilisations pour le traitement et la prevention des recidives des affections par helicobacter |
DE19703437A1 (de) * | 1997-01-30 | 1998-08-06 | Luitpold Pharma Gmbh | Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen |
GB2325233B (en) * | 1997-05-16 | 2001-07-18 | Norsk Hydro As | Substrates having bound polysaccharides and bacterial nucleic acids |
US6610293B1 (en) * | 1997-06-16 | 2003-08-26 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
US7250494B2 (en) * | 1998-06-15 | 2007-07-31 | Biosynexus Incorporated | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
CA2338665C (en) | 1998-08-06 | 2011-01-18 | Mountain View Pharmaceuticals, Inc. | Peg-urate oxidase conjugates and use thereof |
WO2002045742A2 (en) * | 2000-09-12 | 2002-06-13 | U.S. Army Medical Research And Materiel Command | Lipoteichoic acid immunogenic compositions and methods of making and using thereof |
GB2370838A (en) * | 2001-01-06 | 2002-07-10 | Benedikt Timmerman | Immunogenic complex |
GB2370839A (en) * | 2001-01-06 | 2002-07-10 | Benedikt Timmerman | Immunogenic complex useful for disease control |
CA2463008A1 (en) * | 2001-10-26 | 2003-07-24 | Id Biomedical Corporation Of Washington | Efficient protein expression system |
US20080159976A1 (en) * | 2005-04-11 | 2008-07-03 | Jacob Hartman | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
SG2014009484A (en) | 2005-04-11 | 2014-05-29 | Savient Pharmaceuticals Inc | A variant form of urate oxidase and use thereof |
US8148123B2 (en) | 2005-04-11 | 2012-04-03 | Savient Pharmaceuticals, Inc. | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
ES2538357T3 (es) | 2005-04-11 | 2015-06-19 | Crealta Pharmaceuticals Llc | Formas variantes de urato oxidasa y uso de las mismas |
US20090081122A1 (en) * | 2005-05-23 | 2009-03-26 | Universite De Geneve | Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant |
ES2532804T3 (es) | 2006-04-12 | 2015-03-31 | Crealta Pharmaceuticals Llc | Purificación de proteínas con tensioactivo catiónico |
US9377454B2 (en) | 2009-06-25 | 2016-06-28 | Crealta Pharmaceuticals Llc | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy |
US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3725545A (en) * | 1971-02-03 | 1973-04-03 | R Maes | Enhancement of antibody production by nucleic acid-polycation complexes |
FR2253499B1 (ja) * | 1973-12-10 | 1977-11-04 | Fabre Sa Pierre | |
US3952097A (en) * | 1974-09-27 | 1976-04-20 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid |
FR2305990A1 (fr) * | 1975-04-02 | 1976-10-29 | Fabre Sa Pierre | Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens |
FR2360314A2 (fr) * | 1976-08-06 | 1978-03-03 | Fabre Sa Pierre | Nouveaux vaccins perfectionnes a base de fractions ribosomales |
FR2374911A1 (fr) * | 1976-12-21 | 1978-07-21 | Fabre Sa Pierre | Adjuvants d'immunite non specifique |
FR2388563A1 (fr) * | 1977-04-29 | 1978-11-24 | Fabre Sa Pierre | Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires |
US4285930A (en) * | 1977-12-08 | 1981-08-25 | Likhite Vilas V | Antigens comprising immunostimulant adjuvants and their use in immunotherapy |
-
1980
- 1980-02-20 FR FR8003707A patent/FR2475900A1/fr active Granted
-
1981
- 1981-02-19 DE DE8181400258T patent/DE3170913D1/de not_active Expired
- 1981-02-19 AT AT81400258T patent/ATE13741T1/de not_active IP Right Cessation
- 1981-02-19 CA CA000371264A patent/CA1181691A/en not_active Expired
- 1981-02-19 EP EP81400258A patent/EP0035429B1/fr not_active Expired
- 1981-02-20 ZA ZA00811125A patent/ZA811125B/xx unknown
- 1981-02-20 US US06/236,534 patent/US4460575A/en not_active Expired - Lifetime
- 1981-02-20 AU AU67501/81A patent/AU543201B2/en not_active Expired
- 1981-02-20 ES ES500567A patent/ES500567A0/es active Granted
- 1981-02-20 JP JP2418381A patent/JPS56131523A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE3170913D1 (en) | 1985-07-18 |
US4460575A (en) | 1984-07-17 |
FR2475900A1 (fr) | 1981-08-21 |
EP0035429A1 (fr) | 1981-09-09 |
FR2475900B1 (ja) | 1983-06-10 |
AU543201B2 (en) | 1985-04-04 |
ATE13741T1 (de) | 1985-06-15 |
ZA811125B (en) | 1982-03-31 |
AU6750181A (en) | 1981-08-27 |
CA1181691A (en) | 1985-01-29 |
ES8203226A1 (es) | 1982-04-16 |
ES500567A0 (es) | 1982-04-16 |
EP0035429B1 (fr) | 1985-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS56131523A (en) | Vaccine composite containing idiosyncratic antigen and vaccine containing idiosyncratic antigen | |
JPS5791915A (en) | Novel lipid composition useful for dietetics, resuscitation and treatment | |
GR77437B (ja) | ||
ZA837603B (en) | Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine | |
IT7928199A0 (it) | Composizione esplosiva del tipo in emulsione e metodo per la sua preparazione. | |
IL62267A0 (en) | Labeled antibodies,compositions containing them and methods for the use thereof | |
IL65835A (en) | Protozoal antigen,its preparation and vaccine containing it | |
JPS57116100A (en) | Novel d-homosteroid | |
ZA807985B (en) | Immunostimulating preparations based on ribosomal rna's and a process for the preparation of the rna's | |
IL59841A (en) | Babesiosis antigen and vaccine and diagnostic agent comprising it | |
IL65496A (en) | Protozoal antigen,its preparation and vaccine containing it | |
AU525403B2 (en) | Purified antigen | |
DE3361874D1 (en) | Unsaturated oximes, preparation thereof and use thereof as perfume and in the fragment compositions | |
FR2513122B1 (ja) | ||
IE792390L (en) | Hepatitis be antigen. | |
GR73033B (ja) | ||
IL58677A0 (en) | Process for the preparation of 1 ,3 -dihydroxy- -steroids and intermediates useful in the process | |
GB2062463B (en) | Babesiosis vaccine | |
GB8420358D0 (en) | Natural chelates | |
EP0309898A3 (en) | Method for the induction of a cytotoxic t cell response | |
IL69624A0 (en) | 1,2,3,4-tetrahydro-1-aminomethyl-4-phenyl-isoquinolines and their preparation | |
DE69130953D1 (de) | Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie | |
PT72211A (en) | Improvements in or relating to character recognition apparatus | |
Macoosh | Algebraic closures for commutative rings | |
GB2127694B (en) | Improvements in or relating to autoclaves |